Utility of HbA1c in the detection of subclinical post renal transplant diabetes

Transplantation

Volumn 81, Issue 3, 2006, Pages 379-383

  Hoban, Rebecca ^a   Gielda, Benjamin ^a   Temkit, M'Hamed ^a   Saha, Chandan ^a   Book, Benita K ^a   Baker, Elizabeth ^a   Pescovitz, Mark D ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Calcineurin; Complication; HbA1c; Kidney; Posttransplant diabetes; Race ethnicity; Risk factors

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN A; HEMOGLOBIN A1C; STEROID; TACROLIMUS;

ADULT; AFRICAN AMERICAN; AGED; ANAMNESIS; ARTICLE; BODY MASS; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; FISHER EXACT TEST; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; POSTRENAL TRANSPLANT DIABETES; PRIORITY JOURNAL; RACE; RISK FACTOR; SCREENING TEST;

ADOLESCENT; ADULT; AGED; DIABETES MELLITUS; EARLY DIAGNOSIS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 32844471277     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000188622.00840.13     Document Type: Article

References (24)

1. ADA. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005; 28(suppl 1): S37.
2. Ko GTC, Chan JCN, Woo J, Cockram CS. Use of the 1997 American-Diabetes Association diagnostic criteria for diabetes in a Hong Kong Chinese population. Diabetes Care 1998; 21: 2094.
3. Harris MI, Eastman RC, Cowie CC, et al. Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria. Diabetes Care 1997; 20: 1859.
4. Sato T, Inagaki A, Uchida K, et al. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy. Transplantation 2003; 76: 1320.
5. Davidson J, Wilkinson A, Dantal J, et al. New-onset diabetes after transplantation: 2003 international consensus guidelines. Transplantation 2003; 75 (suppl): SS3-SS24.
6. Vesco L, Busson M, Bedrossian J, et al. Diabetes mellitus after renal transplantation: characteristics, outcome, and risk factors. Transplantation 1996.
7. Panz VR, Bonegio R, Raal FJ, et al. Diabetogenic effect of tacrolimus in South African patients undergoing kidney transplantation 1. Transplantation 2002; 73: 587.
8. Moore R, Boucher A, Carter J, et al. Diabetes mellitus in transplantation: 2002 consensus guidelines. Transplant Proc 2003; 35: 1265.
9. First MR. Case 2: Post-transplant diabetes mellitus in renal transplantation. Transplantation 2001; 71: 1872.
10. Miles AM, Sumrani N, Horowitz R, et al. Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes? Transplantation 1998; 65: 380.
11. van Duijnhoven EM, Christiaans MH, Boots JM, et al. Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression. J Am Soc Nephrol 2002; 13: 213.
12. First MR. Posttransplant diabetes mellitus. Transplantation 2003; 10: 1769.
13. First MR, Gerber DA, Hariharan S, et al. Posttransplant diabetes mellitus in kidney allograft recipients: incidence, risk factors, and management. Transplantation 2002; 73: 379.
14. Neylan JF. Racial differences in renal transplantation after immunosuppression with Tacrolimus versus Cyclosporine. Transplantation 1998; 65: 515.
15. Maes BD, Kuypers D, Messiaen T, et al. Transplantation 2001; 72: 1655.
16. Hricik DE, Anton HA, Knauss TC, et al. Outcomes of African American kidney transplant recipients treated with sirolimus, tacrolimus, and corticosteroids. Transplantation 2002; 74: 189.
17. Mayfield J. Diagnosis and classification of diabetes mellitus: new criteria. Am Fam Physician 1998; 58: 1369.
18. Midtvedt K, Hartmann A, Hjelmesaeth J, et al. Insulin resistance is a common denominator of post-transplant diabetes mellitus and impaired glucose tolerance in renal transplant recipients. Nephrol Dial Transplant 1998; 13: 427.
19. Tavintharan S, Chew LS, Heng DM. A rational alternative for the diagnosis of diabetes mellitus in high risk individuals. Ann Acad Med Singapore 2000; 29: 213.
20. Knowler WC. Screening for NIDDM. Opportunities for detection, treatment, and prevention. Diabetes Care 1994; 17: 445.
21. Peters AL, Davidson MB, Schriger DL, Hasselblad V. A clinical approach for the diagnosis of diabetes mellitus. An analysis using glycosylated hemoglobin levels. JAMA 1996; 276: 1246.
22. Perry RC, McGill J, Shankar RR, et al. HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose. Diabetes Care 2001; 24: 465.
23. Harris MI. Undiagnosed NIDDM Clinical and Public Health Issues. Diabetes Care 1993; 16: 642.
24. Krentz AJ, Wheeler DC. New-onset diabetes after transplantation: a threat to graft and patient survival. Lancet 2005; 365: 640.